A-tract and (+)-CC-1065-induced bending of DNA. Comparison of structural features using non-denaturing gel analysis, hydroxyl-radical footprinting, and high-field NMR.
A-tract and (+)-CC-1065-induced bending of DNA. Comparison of structural features using non-denaturing gel analysis, hydroxyl-radical footprinting, and high-field NMR.
复制标题
A-tract 和 ( )-CC-1065 诱导的 DNA 弯曲。
DOI:
10.1021/bi00068a003
复制
发表时间:
1993
期刊:
影响因子:
2.9
通讯作者:
Hurley,LH
中科院分区:
文献类型:
--
作者:
Sun,D;Lin,CH;Hurley,LH
Revised Manuscript Received February 9, 1993 abstract:(+)-CC-1065 is a biologically potent DNA-reactive antitumor antibiotic produced by Streptomyces zelensis. In a previous study we have reportedthat (+)-CC-1065 produces bending of DNA that has similarities to that intrinsically associated with A-tracts [Lin, C. H., Sun, D., & Hurley, L. H.(1991) Chem. Res. Toxicol. 4, 21-26]. In this article we provide evidence using a combination of non-denaturing gel analysis, hydroxyl-radical footprinting, and high-field NMR for both distinctions between the two types of bends andthe importance of junctions in both types of bends. For A-tracts we demonstrate that the locus of bending is at the center of an A-tract and that upon modification of the 3'adenine with (+)-CC-1065 this locus is moved less than 1 base pair to the 3'side, and the bending magnitude is significantly increased. Fordrug bonding sequences such as 5'-AGTTA* or 5'-GATTA*(where* denotes the drug bonding site), the locus of bending is found to be betweenthe two thymines, and the bending is focused over a 2-base-pair sequence rather than a 5-base-pair sequence, as is the case for the A-tract. An important distinction between an A-tract intrinsic bend and a (+)-CC-1065-induced bend is the effect of temperature. While, as shown previously, the magnitude of A-tract bending increases with decrease in temperature, for drug-induced bending of 5'-AGTTA* the bending magnitude increases with increased temperature. Hydroxylradical footprintingof the drug-modified 5'-AGTTA* sequence shows a decrease in cleavage centered around the TT sequence, which is presumably associated with a decrease in minor groove width. In a parallel study, the non-self-complementary 12-mer duplex (5/-GGCGGAGTTA* GG-3')'(5'-CCTAACTC-CGCC-3')(Figure 2B) and the corresponding (+)-CC-1065-modified duplex adduct were examined thoroughly by one-and two-dimensional'H NMR and NOESY restrained molecular mechanics and dynamics calculations. Both the 12-mer duplex and the (+)-CC-1065-12-mer duplex adduct maintain an overall B-form DNA with the anti base orientation throughout in aqueous solution at room temperature. The 18C nucleotide of both the 12-mer duplex and its drug-modified adduct has an average C3'-endo sugar pucker. The 12-mer duplex exhibits a unique internal motion at the 16A nucleotide, which is located to the 3'side of the complementary partner of the covalentlymodified adenine, and a major kink at the 18C-19T step. Following covalent bonding with (+)-CC-1065, the discontinuity around18C is entrapped and further exaggerated. In addition, the 12-mer duplex adduct displays a compression of the minor groove at the 8T to 9T step and widening on both sides, but especially abruptly at the covalent modification site. Structurally, the 12-mer duplex adduct bears many similarities to a bent DNA structure, which is intrinsically associated with A-tracts. The major drug-induced distortion on DNA is localized at the 9T and 10A step of the covalently modified strand. A truncated junction model for the drug-entrapped/induced bending of DNA is proposed, and a comparison to intrinsic A-tract bending is made.(+)-CC-1065 (Figure 1) is an extremely potent antitumor antibiotic produced by Streptomyces zelensis (Hanka et al., 1978).(+)-CC-1065 reacts with double-stranded DNA through N3 of a reactive adenine, forming a covalent adduct that overlaps a 5-bp1 region in the minor groove (Swenson et al., 1982; Hurley et al., 1984; Scahill et al., 1990).(+)-CC-1065 consists of a CPI subunit (subunit A in Figure 1) and
登录
查看更多内容
影响因子:
2.9
作者:
Lin,CH;Beale,JM;Hurley,LH
通讯作者:
Hurley,LH
影响因子:
2.9
作者:
HURLEY, LH;LEE, CS;ARISTOFF, PA
通讯作者:
ARISTOFF, PA
影响因子:
14.9
作者:
R. Abagyan;V. Mironov;B. Chernov;V. P. Chuprina;A. V. Ulyanov
通讯作者:
A. V. Ulyanov
影响因子:
4.1
作者:
Lin,CH;Sun,DY;Hurley,LH
通讯作者:
Hurley,LH
DOI:
--
发表时间:
1992
期刊:
Anti-cancer drug design
影响因子:
--
作者:
Sun,D;Hurley,LH
通讯作者:
Hurley,LH